RO6889678

RO6889678 Suppliers list
Company Name: HANGZHOU CLAP TECHNOLOGY CO.,LTD
Tel: 86-571-88216897,88216896 13588875226
Email: sales@hzclap.com
Products Intro: Product Name:RO6889678
CAS:1578153-27-1
Purity:99% Package:10kg 25kg 200 kilograms per barrel Remarks:good
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354
Email: support@targetmol.com
Products Intro: Product Name:RO6889678
CAS:1578153-27-1
Package:10 mg;100 mg;2 mg;25 mg;5 mg;50 mg Remarks:REAGENT;FOR LABORATORY USE ONLY
Company Name: Shanghai Guangyang Jiali Biotechnology Co., Ltd
Tel: 13407521611
Email: 46993711@qq.com
Products Intro: CAS:1578153-27-1
Package:2
Company Name: Shanghai meikai technology co., ltd  
Tel: 021-18721550-091 18721550091
Email: yangdong@pharma.com
Products Intro: Product Name:RO6889678
CAS:1578153-27-1
Purity:>95% Package:5 mg|10 mg| Remarks:MC017748
Company Name: ShangHai ChuanQian Chemcial Technique Centre  
Tel: 15869524721
Email: 3525679403@qq.com
Products Intro: CAS:1578153-27-1
Purity:98% HPLC Package:5MG;10MG;50MG;100MG,1G,5G,10G
RO6889678 Basic information
Product Name:RO6889678
Synonyms:RO6889678;3-Morpholinecarboxylic acid, 4-[[(6R)-6-(2-chloro-4-fluorophenyl)-3,6-dihydro-5-(methoxycarbonyl)-2-(2-thiazolyl)-4-pyrimidinyl]methyl]-, (3S)-;inhibit,Hepatitis B virus,coregulated protein,UDP-glucuronosyltransferase,HB capsid formation,ADME,CYP3A4,RO-6889678,RO6889678,hepatocytes,CYPs,Cytochrome P450,UGT1A3,oxidation,RO 6889678,HBV,UGT1A1,Inhibitor,glucuronidation
CAS:1578153-27-1
MF:C21H20ClFN4O5S
MW:494.92
EINECS:
Product Categories:
Mol File:1578153-27-1.mol
RO6889678 Structure
RO6889678 Chemical Properties
Safety Information
MSDS Information
RO6889678 Usage And Synthesis
DescriptionRO6889678 is an inhibitor of HBV with a complex ADME profile. RO6889678 showed an intracellular enrichment of 78-fold in hepatocytes, with an apparent intrinsic clearance of 5.2 μl/min per mg protein and uptake and biliary clearances of 2.6 and 1.6 μl/min per mg protein, respectively. The induction potential of RO6889678 on cytochrome P450 (P450) enzymes and transporters at steady state was assessed and cotreatment with ritonavir revealed a complex drug-drug interaction with concurrent P450 inhibition and moderate UDP-glucuronosyltransferase induction.
in vitroRO6889678 is a highly potent inhibitor of HBV capsid formation, with attributes that are favorable for targeting the liver while maintaining moderate peripheral exposure._x000D_ _x000D_ Reference: J Pharmacol Exp Ther. 2018 May;365(2):237-248. https://pubmed.ncbi.nlm.nih.gov/29453199/
targetRO6889678 is a highly potent HBV capsid formation inhibitor with a complex absorption, distribution, metabolism, and excretion (ADME) profile. RO6889678 is a potent inducer of CYP3A4 and coregulated proteins in human hepatocytes.
RO6889678 Preparation Products And Raw materials
Tag:RO6889678(1578153-27-1) Related Product Information